Role of SVEP1 in fibrosis, metabolism and blood pressure
dc.contributor.advisor
Conway, Bryan
en
dc.contributor.advisor
Mullins, John
en
dc.contributor.author
Sime, Nicole Elizabeth Lennon
en
dc.contributor.sponsor
other
en
dc.date.accessioned
2018-09-05T09:41:24Z
dc.date.available
2018-09-05T09:41:24Z
dc.date.issued
2018-06-30
dc.description.abstract
Sushi, von Willebrand factor type A, epidermal growth factor and pentraxin domain
containing 1 (SVEP1) is an extracellular matrix protein which may bind to cell surface
molecules such as integrins. A non-synonymous single amino acid polymorphism in
the Svep1 gene is associated with a 14% increased risk of coronary heart disease, a
13% higher risk of type 2 diabetes and a 1mmHg increase in systolic blood pressure.
Expression of the SVEP1 gene is increased in the kidney in the Cyp1a1mRen2 rat
model of diabetes and hypertension previously developed in our lab. SVEP1 is also
known to be upregulated in human diabetic nephropathy and is upregulated in rodent
models of renal fibrosis. I hypothesized that Svep1 played a role in renal fibrosis,
diabetes and blood pressure. Hence, the primary goal of this thesis was to investigate
the role of SVEP1 and in the pathogenesis of diabetes, hypertension and renal fibrosis.
Svep1 gene expression is increased in the kidney in the DOCA-salt-angII-uninephrectomy
model of hypertension and following UUO. SVEP1 hemizygous mice
showed no differences in expression of pro-fibrotic genes after UUO compared to
wildtype littermates. No overt metabolic phenotype was exhibited by the Svep1
hemizygous mice, however there was a significant decrease in fat depot weights after
high fat diet (HFD) and a significant increase in blood glucose concentrations during
the glucose tolerance test at the 12 week time point in hemizygous Svep1 mice
compared with wild-type controls. After telemetry analysis of blood pressure no
difference was seen in blood pressure but SVEP1+/-animals had an increased heart rate
of 100 beats per minute compared to wildtype animals.
Svep1 expression is increased in the kidney in models of hypertension and fibrosis,
however loss of one Svep1 allele did not alter the severity of fibrosis in the UUO model
or significantly alter glucose tolerance after high fat diet. However, the high fat diet
experiment was a pilot study and should be repeated with a larger number of animals.
In addition, generation of a mouse with the human point mutation could determine the
mechanisms by which this extracellular matrix protein confers risk of diabetes and
hypertension.
en
dc.identifier.uri
http://hdl.handle.net/1842/31554
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.subject
SVEP1
en
dc.subject
kidney disease
en
dc.subject
diabetes
en
dc.subject
high blood pressure.
en
dc.subject
mouse model
en
dc.title
Role of SVEP1 in fibrosis, metabolism and blood pressure
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Sime2018.pdf
- Size:
- 4.82 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

